|本期目录/Table of Contents|

[1]李 星综述,苏亦平审校.肿瘤患者卵巢储备功能受损机制及保护并促进生育力的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):60-64.[doi:10.3969/j.issn.1672-271X.2020.01.014]
 LI Xing reviewing,SUYi-ping checking.Research progress on ovarian reserve impairment and the preservation and promotion of fertility in tumor patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(01):60-64.[doi:10.3969/j.issn.1672-271X.2020.01.014]
点击复制

肿瘤患者卵巢储备功能受损机制及保护并促进生育力的研究进展()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第22卷
期数:
2020年01期
页码:
60-64
栏目:
综述
出版日期:
2020-01-06

文章信息/Info

Title:
Research progress on ovarian reserve impairment and the preservation and promotion of fertility in tumor patients
作者:
李 星综述苏亦平审校
作者单位:210004 南京,南京医科大学附属妇产医院(南京市妇幼保健院)妇科(李 星、苏亦平)
Author(s):
LI Xing reviewing SU Yi-ping checking
(Department of Gynecology,Obstetrics and Gynecology Hospital,the Affiliated Hospital of Nanjing Medical University, Nanjing 210004,Jiangsu,China)
关键词:
肿瘤化疗卵巢储备功能卵巢组织冻存促性腺激素释放激素激动剂干细胞
Keywords:
tumor chemotherapy ovarian reserve function ovarian tissue cryopreservation gonadotropin-releasing hormone agonist stem cells
分类号:
R737.31
DOI:
10.3969/j.issn.1672-271X.2020.01.014
文献标志码:
A
摘要:
由于青少年和年轻女性肿瘤患者的长期生存率提高,人们越来越关注肿瘤治疗后对卵巢功能及生育的影响。女性肿瘤患者可能就其生育状况寻求建议和治疗,包括如何保护卵巢储备功能及预防卵巢早衰,这可能对其今后的生存质量和心理健康产生深远影响。文章就化疗对卵巢储备功能的损伤机制及现阶段保护卵巢功能的策略和研究进展进行综述。
Abstract:
As the long-term survival rate of adolescent and young female cancer patients increases, more and more attention is given to ovarian function and fertility after tumor treatment. Female cancer patients may seek advice and treatment on their fertility status, including ways to protect ovarian reserve function and prevent premature ovarian failure, which may have a profound impact on their quality of life and mental health in the future. This article reviews the damage mechanism of chemotherapy on ovarian reserve function and the strategies and research progress of protecting ovarian function at present.

参考文献/References:

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. [2] Selter J, Huang Y, Grossman Becht LC, et al. Use of Fertility Preservation Services in Female Reproductive-Aged Cancer Patients [J]. Am J Obstet Gynecol, 2019, 221(4):328.e1-328.e16. [3] Oktay K, Hrvey BE, Partridge AH, et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update [J].J Clin Oncol, 2018, 36(19): 1994-2001. [4] Moore HC, Uunger JM, Philips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy [J].N Engl J Med, 2015, 372(10): 923-932. [5] Senra JC, Roque M, Talim MCT, et al. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis [J]. Ultrasound Obstet Gynecol, 2018, 51(1): 77-86. [6] Gerber B, Von Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study [J]. J Clin Oncol, 2011, 29(17): 2334-2341. [7] Oktay K, Harvey BE, Loren AW. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update Summary [J]. J Oncol Pract, 2018, 14(6): 381-385. [8] Zhou L, Xie Y, Li S, et al. Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo [J]. J Ovarian Res, 2017, 10(1): 56-63. [9] Kalich-Philosoph L, Roness H, Carmely A, et al. Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility [J]. Sci Transl Med,2013, 5(185): 162-185. [10] Pascuali N, Scotti L, Di Pietro M, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure [J].Hum Reprod, 2018, 33(5): 844-859. [11] Niringiyumukiza JD, Cai H, Chen L, et al. Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve [J].Biomed Pharmacother, 2019, 116(108963). [12] Jang H, Lee OH, Lee Y, et al. Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary [J]. J Pineal Res, 2016, 60(3): 336-347. [13] Meng Y, Xu Z, Wu F, et al. Sphingosine-1-phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice [J]. Fertil Steril, 2014, 102(3): 871-877. [14] 张良,范楷,靖俊,等.褪黑素对放疗后大鼠卵巢功能保护作用的探讨[J].医学研究生学报,2014,27(6):592-595. [15] Saitou JM, Yamaji M. Primordial germ cells in mice [J]. Cold Spring Harb Perspect Biol. 2012,4(11). [16] Ge W, Chen C, De Felicl M, et al. In vitro differentiation of germ cells from stem cells: a comparison between primordial germ cells and in vitro derived primordial germ cell-like cells [J]. Cell Death Dis, 2015, 6:e1906. [17] Silvestris E, D’oronzo S, Caffprio P, et al. In Vitro Generation of Oocytes from Ovarian Stem Cells (OSCs): In Search of Major Evidence [J]. Int J Mol Sci, 2019, 20(24)pii:E6225. [18] Bhartiya D, Shaikh A, Anand S, et al. Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead [J]. Hum Reprod Update, 2016, 23(1): 41-76. [19] Aoi T. 10th anniversary of iPS cells: the challenges that lie ahead [J]. J Biochem, 2016, 160(3): 121-129. [20] 陈琪珍,田淑娜,陈雄.CO2高暴露对雌性大鼠生殖系统及胚胎发育的影响[J].东南国防医药,2019,21(2):130-134. [21] 陈翠莹,游可理,陈观娣,等.全子宫及双侧输卵管切除对术后卵巢功能的近期影响[J].医学研究生学报,2017,30(1):83-87. [22] Moawad NS, Santamaria AE, Rhoton-Vlasak A, et al. Laparoscopic Ovarian Transposition Before Pelvic Cancer Treatment: Ovarian Function and Fertility Preservation [J]. J Minim Invasive Gynecol, 2017, 24(1): 28-35. [23] Del Pup L, Salvagno F, Borini A, et al. Ovarian transposition in young women and fertility sparing [J]. Eur Rev Med Pharmacol Sci, 2016, 20(2): 197-198. [24] Zhang CH, Wu L, Li PQ. Clinical study of the impact on ovarian reserve by different hemostasis methods in laparoscopic cystectomy for ovarian endometrioma [J]. Taiwan J Obstet Gynecol, 2016, 55(4): 507-511. [25] Asgari Z, Rouholamin S, Hosseini R, et al. Comparing ovarian reserve after laparoscopic excision of endometriotic cysts and hemostasis achieved either by bipolar coagulation or suturing: a randomized clinical trial [J]. Arch Gynecol Obstet, 2016, 293(5): 1015-1022. [26] Candiani M, Ottolina J, Posadzka E, et al. Assessment of ovarian reserve after cystectomy versus ’one-step’ laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial [J]. Human Reprod, 2018, 33(12): 2205-2211. [27] 戴凤英,曾清芳,洪丽君.腹腔镜下囊肿剥除联合垂体后叶素治疗卵巢子宫内膜异位囊肿的临床分析[J].东南国防医药,2015,17(6):645-647. [28] Kim SY, Kim SK, Lee JR, et al. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women [J]. J Gynecol Oncol, 2016, 27(2): e22. [29] Oktay K, Turan V, Bedoschi G, et al. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer [J]. J Clini Oncol, 2015, 33(22): 2424-2429. [30] He Y, Wu H, He X, et al. Administration of atosiban in patients with endometriosis undergoing frozen-thawed embryo transfer: a prospective, randomized study [J]. Fertil Steril, 2016, 106(2): 416-422. [31] Toftager M, Bogstad J, Lossl K, et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols [J]. Hum Reprod, 2017, 32(3): 556-567. [32] 秦文松,刘英,秦辉灵, 等.人卵母细胞玻璃化冷冻技术在辅助生殖中的应用[J].中国性科学,2015(2):93-95. [33] Doyle JO, Richter KS, Lim J, et al. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval [J]. Fertil Steril, 2016, 105(2): 459-466. [34] Shi Y, Sun Y, Hao C, et al. Transfer of Fresh versus Frozen Embryos in Ovulatory Women [J]. N Engl J Med, 2018, 378(2): 126-136. [35] Cobo A, Garrido N, Pellicer A, et al. Six years’ experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate [J]. Fertil Steril, 2015, 104(6): 1426-1434. [36] Cobo A, Garcia-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation [J]. Fertil Steril, 2016, 105(3): 755-764. [37] Gellert SE, Pors SE, Kristensen SG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort [J]. J Assist Reprod Genet, 2018, 35(4): 561-570. [38] Demeestere I, Simon P, Dedeken L, et al. Live birth after autograft of ovarian tissue cryopreserved during childhood [J]. Hum Reprod, 2015, 30(9): 2107-2109. [39] Pacheco F, Oktay K. Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis [J]. Reprod Sci, 2017, 24(8): 1111-1120. [40] Van Der Ven H, Liebenthron J, Beckmann M, et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates [J]. Hum Reprod, 2016, 31(9): 2031-2041. [41] Dolmans MM, Masciangelo R. Risk of transplanting malignant cells in cryopreserved ovarian tissue [J]. Minerva Ginecol, 2018, 70(4): 436-443. [42] Kristensen SG, Giorgione V, Humaidan P, et al. Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence [J]. Fertil Steril, 2017, 107(5): 1206-1213. [43] Creux H, Monnier P, Son WY, et al. Thirteen years’ experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments [J]. J Assist Reprod Genet, 2018, 35(4): 583-592. [44] Chiti MC, Dolmans MM, Moetiaux L, et al. A novel fibrin-based artificial ovary prototype resembling human ovarian tissue in terms of architecture and rigidity [J]. J Assist Reprod Genet, 2018, 35(1): 41-48. [45] Dolmans MM, Amorim CA. Construction and use of artificial ovaries [J]. Reproduction, 2019,83(1):612-623.

相似文献/References:

[1]祝斐,黄新,陈谦学,等.神经内镜切除脑室内实质性肿瘤[J].医学研究与战创伤救治(原医学研究生学报),2013,15(02):152.
 .Department of Neurosurgery,Lushan Sanatorium of Nanjing Military Command,Jiujiang,et al.ZHU Fei1,HUANG Xin1,CHEN Qian-xue2[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(01):152.
[2]孙 标综述,李向阳校审.PIM与消化系统肿瘤[J].医学研究与战创伤救治(原医学研究生学报),2012,14(04):345.
[3]高大志,张宗军,郑 玲.颅盖骨单发肿瘤的MRI诊断[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):452.
[4]卢 杰,王玉秀,张应祥,等.全身热疗对肿瘤患者肺换气功能的影响[J].医学研究与战创伤救治(原医学研究生学报),2011,13(02):130.
 LU Jie,WANG Yu-xiu,ZHANG Ying-xiang,et al.Effect of whole body hyperthermia on pulmonary gas exchange in patients with malignant tumors[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(01):130.
[5]王学文.EB病毒淋巴增殖的治疗进展[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):325.
[6]黄乐林,沈艳喜,李 伟,等.肿瘤全身高温疗法的20例临床麻醉管理[J].医学研究与战创伤救治(原医学研究生学报),2009,11(01):33.
 HUANG Le-lin,SHEN Yan-xi,LI Wei,et al.Anesthesia manipulation for 20 cancer patients with whole body hyperthermia[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(01):33.
[7]戴英,张南征,刘军权,等.过继性细胞免疫治疗2 500例的护理观察[J].医学研究与战创伤救治(原医学研究生学报),2009,11(05):405.
 DAI Ying,ZHANG Nan-zheng,LIU Jun-quan,et al.Nursing of 2 500 patients with adoptive cellular immunotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(01):405.
[8]蒋静.鼻咽癌化疗患者恶心呕吐的护理[J].医学研究与战创伤救治(原医学研究生学报),2009,11(05):404.
[9]沈 杰,马爱英,刘秋如,等.经皮微波凝固综合治疗转移性肝癌[J].医学研究与战创伤救治(原医学研究生学报),2008,10(01):19.
 SHEN Jie,MA Ai-ying,LIU Qiu-ru,et al.Percutaneous microwave coagulation comprehensive therapy for metastatic liver cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(01):19.
[10]冯萍娟,蔡丽萍,刘桂苏.超声引导下甲状腺肿瘤穿刺组织活检对良恶性 的诊断价值[J].医学研究与战创伤救治(原医学研究生学报),2008,10(01):47.
[11]黄迎娣,崔 蕾,黄利鸣综述,等.上皮间质转化与肿瘤耐药[J].医学研究与战创伤救治(原医学研究生学报),2014,16(06):624.[doi:10.3969/j.issn.1672-271X.2014.06.020]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81871138)
更新日期/Last Update: 2020-01-06